Literature DB >> 6815654

Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation.

J S Pober, M A Gimbrone.   

Abstract

The expression of Ia-like antigens by cultured human endothelial cells has been investigated by means of monoclonal antibody binding to intact cells and by immunoprecipitation of radioiodinated membrane proteins. Primary growing and confluent cultures of human umbilical vein endothelium express little, if any, detectable Ia-like antigens under standard culture conditions. However, treatment of primary cultures with the lectin phytohemagglutinin induces the expression of Ia-like antigens. This action of the lectin uniformly affects all the endothelial cells in a culture, does not depend on cell division, and is associated with a cell shape change. The data presented in this report provide unequivocal serological and biochemical demonstration of Ia-like antigens on human vascular endothelial cells. The fact that the expression of Ia-like antigens by endothelium can be induced may have important implications for organ transplantation and for regulation of the immunological response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815654      PMCID: PMC347184          DOI: 10.1073/pnas.79.21.6641

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  HLA-D region products are expressed in endothelial cells.

Authors:  T Moen; M Moen; E Thorsby
Journal:  Tissue Antigens       Date:  1980-02

3.  The human mixed lymphocyte-endothelium culture interaction.

Authors:  H Hirschberg; S A Evensen; T Henriksen; E Thorsby
Journal:  Transplantation       Date:  1975-06       Impact factor: 4.939

4.  A new antigen system expressed in human endothelial cells.

Authors:  J R Moraes; P Stastny
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

5.  Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera.

Authors:  H Hirschberg; T Moen; E Thorsby
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Antigens on mouse and rat lymphocytes recognized by rabbit antiserum against rat brain: the quantitative analysis of a xenogeneic antiserum.

Authors:  R J Morris; A F Williams
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

8.  Rapid purification of detergent-solubilized HLA antigen by affinity chromatography employing anti-beta2-microglobulin serum.

Authors:  R J Robb; J L Strominger
Journal:  J Biol Chem       Date:  1976-09-10       Impact factor: 5.157

9.  Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen.

Authors:  R E Humphreys; J M McCune; L Chess; H C Herrman; D J Malenka; D L Mann; P Parham; S F Schlossman; J L Strominger
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

10.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

View more
  40 in total

Review 1.  Endothelial cell heterogeneity and atherosclerosis.

Authors:  William C Aird
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

2.  Reperfusion injury following cold ischemia activates rat liver Kupffer cells.

Authors:  P N Rao; T Liu; J T Synder; J L Platt; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Tissue culture of human and canine thoracic duct endothelium.

Authors:  D R Gnepp; W Chandler
Journal:  In Vitro Cell Dev Biol       Date:  1985-04

4.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.

Authors:  A H Stolpen; E C Guinan; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

Review 5.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

6.  Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis.

Authors:  L Jonasson; J Holm; O Skalli; G Gabbiani; G K Hansson
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation.

Authors:  Z Szekanecz; M R Shah; W H Pearce; A E Koch
Journal:  Agents Actions       Date:  1994-10

8.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors:  T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  The use of angiostatic steroids to inhibit cartilage destruction in an in vivo model of granuloma-mediated cartilage degradation.

Authors:  P R Colville-Nash; M el-Ghazaly; D A Willoughby
Journal:  Agents Actions       Date:  1993-01

10.  Differential expression of Ia molecules by human monocytes.

Authors:  T A Gonwa; J D Stobo
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.